Amwell (AMWL) Misses Q1 EPS by 3c

Amwell (NYSE: AMWL) reported Q1 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $64.94 million.

GUIDANCE:

Amwell sees FY2022 revenue of $275-285 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Copart launches $10.50-per-share tender offer to acquire ACV
• Surgery Partners sells Idaho Falls facilities to Intermountain Health for $797M